L’AMCLI dal 1970 si occupa della Microbiologia clinica promuovendo la ricerca scientifica e la formazione, fornendo un supporto valido e insostituibile alla diagnostica clinica delle patologie infettive, con la promozione di percorsi clinico-diagnostici e terapeutici volti a criteri di appropriatezza e standard clinico professionali. Tutto finalizzato al raggiungimento dell’obiettivo primario della “Clinical Governance”, che è quello di favorire lo sviluppo dell’eccellenza nell’assistenza sanitaria.
iscrizioniIscriviti compilando il modulo online per entrare a far parte dell’associazione e scoprire i vantaggi riservati ai soci AMCLI.
rivistaÈ la rivista ufficiale dell’ AMCLI, pubblica papers di ricerca applicata nei settori di: batteriologia, micologia, virologia, parassitologia…
pubblicazioniElenco delle ultime pubblicazioni sostenute da AMCLI: Testo Atlante, infezioni genitali, Micobatteriologia clinica…
leggi e decretiPer rimanere aggiornati sulle ultime leggi e decreti inerenti al mondo della Microbiologia Clinica.
Case Commentary: the Need for Cefiderocol Is Clear, but Are the Supporting Clinical Data? Ryan K. Shields Antimicrob. Agents Chemother. March 2020 64:e00059-20; Accepted manuscript posted online 3 February 2020, doi:10.1128/AAC.00059-20 FREE Cefiderocol is a newly approved siderophore cephalosporin that demonstrates expanded in vitro activity......
A Multispecies Cluster of VIM-1 Carbapenemase-Producing Enterobacterales Linked by a Novel, Highly Conjugative, and Broad-Host-Range IncA Plasmid Forebodes the Reemergence of VIM-1 Gabriele Arcari, Federica Maria Di Lella, Giulia Bibbolino, Fabio Mengoni, Marzia Beccaccioli, Guido Antonelli, Luigi Faino and Alessandra Carattoli Antimicrob. Agents Chemother. March......
Covid Reference Kamps BS, Hoffmann C Steinhauser Verlag, 2020 PDF, 110 pag. Segnalato dal Prof. Pasquale Urbano OPEN...
Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018) Michael A. Pfaller, Cecilia Carvalhaes, Shawn A. Messer, Paul R. Rhomberg and Mariana Castanheira Antimicrob. Agents Chemother. March 2020 64:e00099-20; Accepted manuscript posted online......
Antagonistic Effect of Colistin on Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus in In Vitro and In Vivo Studies Sungim Choi, Song Mi Moon, Su-Jin Park, Seung Cheol Lee, Kyung Hwa Jung, Heung-sup Sung, Mi-Na Kim, Jiwon Jung, Min Jae Kim, Sung-Han Kim, Sang-Oh Lee, Sang-Ho......
In Vitro Susceptibility of Thai Pythium insidiosum Isolates to Antibacterial Agents Navaporn Worasilchai, Ariya Chindamporn, Rongpong Plongla, Pattama Torvorapanit, Kasama Manothummetha, Nipat Chuleerarux and Nitipong Permpalung Antimicrob. Agents Chemother. March 2020 64:e02099-19; Accepted manuscript posted online 3 February 2020, doi:10.1128/AAC.02099-19 Human pythiosis is a life-threatening......
In Vitro Evaluation of Antifungal Drug Combinations against Multidrug-Resistant Candida auris Isolates from New York Outbreak Brittany O’Brien, Sudha Chaturvedi and Vishnu Chaturvedi Antimicrob. Agents Chemother. March 2020 64:e02195-19; Accepted manuscript posted online 13 January 2020, doi:10.1128/AAC.02195-19 Since 2016, New York hospitals and health care......
Assessment of Tedizolid In Vitro Activity and Resistance Mechanisms against a Collection of Enterococcus spp. Causing Invasive Infections, Including Isolates Requiring an Optimized Dosing Strategy for Daptomycin from U.S. and European Medical Centers, 2016 to 2018 Cecilia G. Carvalhaes, Helio S. Sader, Robert K. Flamm,......
Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection Brandon J. Webb, Aruna Subramanian, Bert Lopansri, Bruce Goodman, Peter Bjorn Jones, Jeffrey Ferraro, Edward Stenehjem and Samuel M. Brown Antimicrob. Agents Chemother. March 2020 64:e02169-19; Accepted manuscript posted online 21 January 2020, doi:10.1128/AAC.02169-19 Clostridioides difficile......